Patent 8357371 was granted and assigned to Regeneron Pharmaceuticals, Inc. on January, 2013 by the United States Patent and Trademark Office.
The present invention provides methods for treating hypercholesterolemia. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an anti-PCSK9 antibody or antigen-binding fragment thereof.